Dr. Reddy's Laboratories Ltd. (RDY)
12.25
0.00 (0.00%)
USD |
NYSE |
Oct 02, 16:00
12.26
0.00 (0.00%)
After-Hours: 20:00
Dr. Reddy's Laboratories Market Cap : 10.20B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.20B |
| October 01, 2026 | 10.20B |
| September 30, 2026 | 10.51B |
| September 29, 2026 | 10.70B |
| September 28, 2026 | 10.42B |
| September 25, 2026 | 10.20B |
| September 24, 2026 | 10.25B |
| September 23, 2026 | 10.32B |
| September 22, 2026 | 10.47B |
| September 21, 2026 | 10.33B |
| September 18, 2026 | 10.15B |
| September 17, 2026 | 10.15B |
| September 16, 2026 | 9.729B |
| September 15, 2026 | 9.621B |
| September 14, 2026 | 9.921B |
| September 11, 2026 | 9.913B |
| September 10, 2026 | 9.754B |
| September 09, 2026 | 9.896B |
| September 08, 2026 | 9.896B |
| September 04, 2026 | 9.971B |
| September 03, 2026 | 10.02B |
| September 02, 2026 | 10.14B |
| September 01, 2026 | 10.14B |
| August 31, 2026 | 10.10B |
| August 28, 2026 | 10.15B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.13B |
| August 26, 2026 | 10.18B |
| August 25, 2026 | 10.28B |
| August 24, 2026 | 10.18B |
| August 21, 2026 | 10.15B |
| August 20, 2026 | 10.09B |
| August 19, 2026 | 10.09B |
| August 18, 2026 | 10.12B |
| August 17, 2026 | 10.09B |
| August 14, 2026 | 10.22B |
| August 13, 2026 | 10.35B |
| August 12, 2026 | 10.32B |
| August 11, 2026 | 10.37B |
| August 10, 2026 | 10.12B |
| August 07, 2026 | 10.18B |
| August 06, 2026 | 10.09B |
| August 05, 2026 | 10.11B |
| August 04, 2026 | 10.08B |
| August 03, 2026 | 10.05B |
| July 31, 2026 | 9.871B |
| July 30, 2026 | 9.854B |
| July 29, 2026 | 9.796B |
| July 28, 2026 | 9.771B |
| July 27, 2026 | 9.804B |
| July 24, 2026 | 9.821B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 56.45B |
| Teva Pharmaceutical Industries Ltd. | 46.05B |
| Novo Nordisk A/S | 124.87B |
| AstraZeneca PLC | 486.65B |
| ANI Pharmaceuticals, Inc. | 1.658B |
Market Cap Related Metrics
| PE Ratio | 27.53 |
| PS Ratio | 2.791 |
| Price to Book Value | 2.519 |
| Price to Free Cash Flow | 134.26 |
| Price | 12.25 |
| Earnings Yield | 3.63% |
| Operating PE Ratio | 27.70 |